SCHEMBL8403306

SCHEMBL8403306

Cc1c([N+](=O)[O-])ccc2c1OCCO2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TXNRD1 Q16881 1/20 0.50
TXNRD3 Q86VQ6 1/20 0.50
TXNRD2 Q9NNW7 1/20 0.50
TDP1 Q9NUW8 1/20 0.46
MAPT P10636 4/20 0.45
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
ALDH1A1 P00352 7/20 0.43
HTT P42858 2/20 0.43
TSHR P16473 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ADRA2A P08913 2/20 0.39
ADRA2C P18825 2/20 0.39
ADRA1D P25100 2/20 0.39
ADRA1A P35348 2/20 0.39
ADRA1B P35368 2/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8403300 0.86 TXNRD1 (0.68) TXNRD1TXNRD3TXNRD2TDP1MAPT
SCHEMBL13015521 0.81 TXNRD1 (0.75) TXNRD1TXNRD3TXNRD2MAPTNPC1
SCHEMBL17099743 0.79 TXNRD1 (0.50) TXNRD1TXNRD3TXNRD2TDP1MAPT
SCHEMBL22804232 0.79 TXNRD1 (0.50) TXNRD1TXNRD3TXNRD2MAPTNPC1
SCHEMBL13015522 0.79 TXNRD1 (0.46) TXNRD1TXNRD3TXNRD2TDP1MAPT
SCHEMBL24992426 0.78 TXNRD1 (0.45) TXNRD1TXNRD3TXNRD2MAPTNPC1
SCHEMBL11262989 0.76 TXNRD1 (0.46) TXNRD1TXNRD3TXNRD2TDP1MAPT
SCHEMBL27500902 0.76 TSHR (0.42) TXNRD1TXNRD3TXNRD2TDP1MAPT
SCHEMBL2962443 0.75 MAPT (0.47) TXNRD1TXNRD3TXNRD2TDP1MAPT
SCHEMBL11261929 0.74 TXNRD1 (0.45) TXNRD1TXNRD3TXNRD2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965595-A SIDE EFFECT REDUCTION; TREATING NASAL CONGESTION AND OTHER ALPHA-2 ADRENORECEPTOR MODULATED DISORDERS, WILL NOT CAUSE HYPERTENSION THE PROCTER & GAMBLE COMPANY (US) 1999-10-12 US disclosed
US-5914342-A 2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists THE PROCTER & GAMBLE COMPANY (US) 1999-06-22 US disclosed
US-5663189-A RESPIRATORY, EYES, GASTROINTESTINAL THE PROCTER & GAMBLE COMPANY (US) 1997-09-02 US disclosed